Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Clin Exp Obstet Gynecol ; 40(2): 289-90, 2013.
Article in English | MEDLINE | ID: mdl-23971262

ABSTRACT

This is a case report of a unique, late-presenting, Müllerian anomaly in an infertile patient. The authors discuss the diagnostic challenges of characterizing distorted gynecological anatomy by Müllerian anomalies in the presence of sizeable coexisting fibroids. This case report adds new insight to the already-existing understanding of Müllerian anomalies by demonstrating how a symptomatic and benign uterine pathology can complicate the diagnosis and management of patients with Müllerian defects.


Subject(s)
Leiomyoma/complications , Mullerian Ducts/abnormalities , Uterine Neoplasms/complications , Uterus/abnormalities , Adult , Cervix Uteri/abnormalities , Female , Humans , Infertility, Female/etiology , Leiomyoma/surgery , Ureter/abnormalities , Uterine Neoplasms/surgery , Uterus/surgery
2.
Clin Exp Obstet Gynecol ; 35(4): 284-6, 2008.
Article in English | MEDLINE | ID: mdl-19205445

ABSTRACT

BACKGROUND: This case evaluates a patient with abdominal pain who presented with a pelvic mass and imaging studies suspicious for malignancy. CASE: A 21-year-old, gravida 0, para 0, was admitted after presenting to the outpatient with abdominal pain. Ultrasound revealed a large 17 x 20 cm pelvic mass with solid and cystic components. CT scan revealed worrisome findings including the finding of "omental caking" and nodal enlargement. CA 125 was elevated at 85 U/ml. Final pathology after surgical removal of the mass showed evidence of serous cystadenoma with ovarian torsion without signs of malignancy. The patient had an unremarkable postoperative course and was discharged in stable condition. CONCLUSION: Although uncommon, pelvic masses that are benign may mimic malignant masses with extradnexal inflammation.


Subject(s)
Cystadenoma, Serous/pathology , Omentum/pathology , Ovarian Neoplasms/pathology , Torsion Abnormality/pathology , Cystadenoma, Serous/surgery , Female , Humans , Ovarian Neoplasms/surgery , Ovariectomy , Torsion Abnormality/surgery , Young Adult
3.
Peptides ; 28(10): 1937-44, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17869379

ABSTRACT

We identified, through qPCR, receptor mRNA for a number of gut peptides in female human omental fat: the incretins, GIP and GLP-1, the orexigenic peptides PYY-Y1 and -Y2 and ghrelin, and the anorexigenic peptide obestatin. Four cohorts of women were examined: lean controls (BMI<23), obese (BMI>41), obese diabetic and term pregnant women. Human fat expressed receptor mRNAs for all six peptides. Pregnant women expressed roughly three times as much orphan GPR-39 receptor, a proposed obestatin receptor, than other women and less than half as much of the ghrelin receptor (GHSR-1a). An immunoblot probed with a GPR-39 selective antibody yielded a single band corresponding to the correct molecular weight (52 kDa) for the proposed obestatin receptor. Fluorescent immunohistochemistry of human fat employing the same antibody indicated the receptor protein was localized to the adipocyte cell membrane. The concentration of obestatin circulating in blood was measured in the same cohort of women and was significantly lower in obese and obese diabetic women compared to control.


Subject(s)
Ghrelin/metabolism , Obesity/metabolism , Base Sequence , Body Mass Index , Cohort Studies , DNA Primers , Female , Humans , Immunohistochemistry , Pregnancy , RNA, Messenger/genetics , Radioimmunoassay , Receptors, Cell Surface/genetics
4.
Invest Ophthalmol Vis Sci ; 41(1): 305-13, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10634635

ABSTRACT

PURPOSE: To investigate the development from early postnatal life to adulthood of neural cell processes that establish the circuitry of the inner plexiform layer (IPL). Emphasis was focused on the ontogeny of subsets of cGMP- and protein kinase C (PKC)immunoreactive amacrine and bipolar cells. METHODS: Paraformaldehyde-fixed postnatal and adult retinas were used for light microscopic analysis of immunohistochemical labeling of cryo-sections. Synthesis of cGMP in neural structures was achieved by means of an in vitro stimulation with a well-established nitric oxide donor. RESULTS: In vitro stimulation of postnatal and mature retina with the nitric oxide donor results in NO-activated cGMP synthesis in subsets of bipolar and amacrine cells. NO-activated cGMP immunoreactivity is expressed in specific cell populations during the first postnatal week. Other cell subsets, consisting of amacrine cells and rod bipolar cells, express PKC immunoreactivity during postnatal development. An increasing number of rod bipolar cells start to exhibit cGMP labeling after eye opening, and a colocalization with PKC is established in adult retinas. Processes from these cell populations terminate in several sublaminas in the developing IPL, but cGMP- and PKC-labeled terminals appear to be confined to ON-lamina as the retina matures. CONCLUSIONS: The development of cGMP- and PKC-labeled fibers within the IPL appears to be in concert with events of neural differentiation and synaptogenesis. These results suggest that the nitric oxide/cGMP signaling pathway and PKC may participate in activity-dependent processes during development that establish the mature circuitry of synaptic contacts within the IPL. The presence of cGMP in mature rod bipolar cells suggests a role in the signal transduction of rod bipolar cell-AII amacrine cell pathway.


Subject(s)
Cyclic GMP/metabolism , Interneurons/metabolism , Nitric Oxide/metabolism , Protein Kinase C/metabolism , Retina/growth & development , Retina/metabolism , Animals , Fluorescent Antibody Technique, Indirect , Interneurons/cytology , Rats , Retina/cytology , Signal Transduction
5.
Endocrinology ; 138(3): 1204-14, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9048628

ABSTRACT

Previous studies have shown that T3 coordinately stimulates GLUT4-glucose transporter messenger RNA (mRNA) and protein expression in mixed fiber-type skeletal muscle of the rat and produces a concomitant elevation in basal (noninsulin mediated) glucose uptake. The aim of the present study was to 1) determine the precise mechanism(s) for the T3-induced expression of GLUT4 in skeletal muscle, and 2) investigate the potential benefits of T3 on noninsulin dependent diabetes mellitus (NIDDM). Ten daily ip injections of T3 (100 micrograms/100 g BW) administered to hypothyroid male Sprague-Dawley rats, increased both GLUT4 mRNA and transcription approximately 70% (P < 0.05) in mixed fiber-type hindlimb skeletal muscle. Transcriptional induction was subsequently defined to be restricted to red (oxidative) muscle fibers (2.5-fold; P < 0.05), whereas GLUT4 protein was increased in both red and white (glycolytic) skeletal muscle. GLUT4 mRNA and protein expression were similarly inducible in the skeletal muscle of insulin-resistant Zucker rats. More importantly, T3 treatment totally ameliorated hyperinsulinemia in obese animals (P < 0.001), although their moderately elevated plasma glucose levels were not significantly altered. In conclusion, regulation of GLUT4 expression by T3 was shown to lie at the transcriptional level in red skeletal muscle, whereas in white muscle fiber types, it appears to operate via an alternative posttranscriptional mechanism. These data also support the potential of hormonally inducing glucose transporter expression in insulin-resistant muscle. However, high levels of T3 are associated with a number of adverse side-effects, in particular the stimulation of hepatic gluconeogenesis. Nevertheless, future studies may demonstrate, e.g. subthyrotoxic levels, to be similarly effective but without side effects, and thus perhaps find a clinical application in reducing both hyperinsulinemia and hyperglycemia in NIDDM.


Subject(s)
Diabetes Mellitus, Type 2/physiopathology , Gene Expression/drug effects , Monosaccharide Transport Proteins/genetics , Muscle Proteins , Triiodothyronine/pharmacology , Animals , Glucose Transporter Type 4 , Hindlimb , Hyperinsulinism/blood , Male , Monosaccharide Transport Proteins/metabolism , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/physiology , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiology , Obesity/blood , Obesity/metabolism , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Rats, Zucker , Transcription, Genetic
6.
J Electron Microsc (Tokyo) ; 46(4): 353-6, 1997.
Article in English | MEDLINE | ID: mdl-9345777

ABSTRACT

The inability to isolate intact collagen fibrils has limited the study of their growth and structure. Although intact fibrils have been isolated from echinoderms and from embryonic chick tissues, no method has previously succeeded in isolating intact collagen fibrils from a postfoetal vertebrate tissue. Having previously observed that gentamicin weakens rat tail tendon, we hypothesized that gentamicin may weaken interfibrillar bonds and that intact collagen fibrils might be isolated from tissue treated with gentamicin. In this study medial collateral knee ligaments of Sprague Dawley rats were transected and then harvested 24, 48 or 96 h postoperatively. These specimens were placed in gentamicin or phosphate-buffered saline for 72 h, vortexed for 1 h, incubated in gentamicin for an additional 24 h, and vortexed again for 1 h. Negatively stained specimens were examined with a transmission electron microscope. The phosphate-buffered saline specimens yielded only broken fibrils. The gentamicin specimens yielded both broken and intact fibrils. The latter and tapering ends and consisted of molecules orientated such that their amino termini pointed toward the tip and their carboxy termini pointed toward a short central region where the molecular polarity reversed.


Subject(s)
Collagen/isolation & purification , Collagen/ultrastructure , Medial Collateral Ligament, Knee/chemistry , Animals , Collagen/chemistry , Gentamicins , Medial Collateral Ligament, Knee/drug effects , Medial Collateral Ligament, Knee/injuries , Microscopy, Electron , Rats , Rats, Sprague-Dawley , Wound Healing
7.
Cell Tissue Res ; 287(1): 161-70, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9011392

ABSTRACT

In this study we sought to determine whether the main components of the nitric oxide (NO) pathway are localized within the Leydig cells of the human testis and whether the soluble guanylyl cyclase (sGC), the enzyme that accounts for NO effects, is functionally active in these cells. Using an amplified immunocytochemical technique, immunoreactivity for nitric oxide synthase (NOS-I), sGC and cyclic guanosine monophosphate (cGMP) was detected within the cytoplasm of human Leydig cells. Distinct differences in staining intensity were found between individual Leydig cells, between cell groups and between Leydig cells of different patients. By means of a specific cGMP-RIA, a concentration-dependent increase in the quantity of cGMP was measured in primary cultures of human Leydig cells following exposure to the NO donor sodium nitroprusside. In addition, NOS-I immunoreactivity was seen in Sertoli cells, whereas cGMP and sGC immunoreactivity was found in Sertoli cells, some apically situated spermatids and residual bodies of seminiferous tubules. Dual-labelling studies and the staining of consecutive sections showed that there are several populations of Leydig cells in the human testis. Most cells were immunoreactive for NOS-I, sGC and cGMP, but smaller numbers of cells were unlabelled by any of the antibodies used, or labelled for NOS-I or cGMP alone, for sGC and cGMP, or for NOS-I and sGC. These results show that the Leydig cells possess both the enzyme by which NO is produced and the active enzyme which mediates the NO effects. There are different Leydig cell populations that probably reflect variations in their functional (steroidogenic) activity.


Subject(s)
Cyclic GMP/metabolism , Guanylate Cyclase/metabolism , Leydig Cells/metabolism , Nitric Oxide Synthase/metabolism , Prostatic Neoplasms/metabolism , Adult , Aged , Aged, 80 and over , Animals , Cells, Cultured , Humans , Leydig Cells/cytology , Male , Middle Aged , Prostatic Neoplasms/pathology , Rats , Rats, Wistar , Testis/cytology , Testis/metabolism
8.
J Neurosci ; 17(1): 363-71, 1997 Jan 01.
Article in English | MEDLINE | ID: mdl-8987761

ABSTRACT

The activation of neurons in the subfornical organ (SFO) by angiotensin II (AngII) is well established and is widely regarded as the basis for the AngII-induced increase in water intake. Application of the nitric oxide (NO) donor sodium nitroprusside (SNP) led to an inhibition of the spontaneous electrical activity in 96% of the neurons sensitive for SNP (n = 50). In addition, the firing rate in 60% of the neurons inhibited by SNP decreased in response to superfusion with the natural substrate of the NO synthase (NOS) L-arginine whereas 70% increased their frequency after application of the NOS blocker NG-monomethyl-L-arginine (L-NMMA; n = 10). The inhibitory effect of SNP could be mimicked by application of membrane-permeable 8-Br-cGMP. The presence of nNOS, the neuronal isoform of NOS, was demonstrated immunocytochemically and using the NADPH-diaphorase technique on SFO slices. Using a highly selective antibody against cGMP in formaldehyde-fixed tissue, the NO donors SNP, 3-morpholinosydnonimine (SIN-1), and S-nitroso-N-acetyl-DL-penicillamine (SNAP) caused a strong increase in cGMP formation when applied under the same conditions as used for the electrophysiological recordings. These electrophysiological results suggest an important role for NO in SFO-mediated responses and offer a plausible explanation for the in vivo-observed opposite effects of AngII and NO on water intake.


Subject(s)
Cyclic GMP/physiology , Neural Inhibition/physiology , Neurons/physiology , Nitric Oxide/physiology , Subfornical Organ/physiology , Animals , Cyclic GMP/analogs & derivatives , Cyclic GMP/pharmacology , Electrophysiology , Immunohistochemistry , In Vitro Techniques , Male , NADPH Dehydrogenase/metabolism , Neurons/drug effects , Nitroprusside/pharmacology , Rats , Rats, Wistar , Staining and Labeling , Subfornical Organ/cytology , Subfornical Organ/drug effects
9.
J Biol Chem ; 271(50): 32276-80, 1996 Dec 13.
Article in English | MEDLINE | ID: mdl-8943287

ABSTRACT

Insulin receptor substrate-1 (IRS-1) is involved in insulin signal transduction distal to receptor occupation. Targeted disruption of IRS-1 leads to insulin resistance and hyperglycemia in mice, which suggests that altered IRS-1 expression could contribute to the insulin resistance seen in non-insulin-dependent diabetes mellitus. In vitro studies using phorbol esters have implicated the protein kinase C (PKC) pathway as being involved in the pathogenesis of insulin resistance. Using the MCF-7 breast cancer cell, a role for PKC in regulating IRS-1 expression was examined. In an MCF-7 cell line (MCF-7-PKC-alpha) that exhibits multiple alterations in PKC isoform expression, IRS-1 content was reduced to negligible levels relative to parental MCF-7 cells. This decrease in IRS-1 content was associated with a 30-fold reduction in IRS-1 transcription. In parental MCF-7 cells, PKC inhibitors (GF109203X (bisindolylmaleimide I) and staurosporine) reduced IRS-1 content. Chronic exposure to 12-O-tetradecanoylphorbol-13-acetate (TPA; >8 h) reduced IRS-1 content and down-regulated the novel PKC-delta isoform. Bryostatin 1 inhibited TPA-induced depletion of both IRS-1 and PKC-delta expression in MCF-7 cells. Associated with TPA-induced reduction in IRS-1 content was a reduction in IRS-1 transcription. These data demonstrate that PKC can modulate IRS-1 content and suggest a potential role for PKC-delta in positively regulating IRS-1 expression.


Subject(s)
Phosphoproteins/metabolism , Protein Kinase C/metabolism , Transcription, Genetic , Animals , Antineoplastic Agents/pharmacology , Bryostatins , Down-Regulation , Enzyme Activation , Female , Humans , Insulin Receptor Substrate Proteins , Insulin Resistance , Isoenzymes/metabolism , Lactones/pharmacology , Macrolides , Mice , Protein Kinase C-delta , Signal Transduction , Tetradecanoylphorbol Acetate/pharmacology , Tumor Cells, Cultured
10.
Clin Infect Dis ; 23(1): 118-24, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8816140

ABSTRACT

The rate of ceftazidime resistance among Klebsiella pneumoniae isolates recovered from patients at the Cleveland Department of Veterans Affairs Medical Center increased from 6% in the first quarter of 1993 to 28% in the first quarter of 1994. The outbreak was hospitalwide, with the highest rates of resistance occurring on wards where ceftazidime was administered most frequently. Although many plasmid patterns were observed in the clinical isolates, molecular epidemiological analysis with use of pulsed field gel electrophoresis revealed substantial similarities between the strains; this finding suggested that most of the strains-if not all of them-were derived from the original clone. The addition of piperacillin/tazobactam to the hospital formulary and educational efforts focused on minimizing the administration of ceftazidime were associated with a marked decrease in the drug's use and a concomitant decrease in the percentage of ceftazidime-resistant isolates. We have not yet observed a significant rise in the rate of resistance to piperacillin/tazobactam among clinical isolates of K. pneumoniae.


Subject(s)
Ceftazidime/pharmacology , Cephalosporins/pharmacology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/isolation & purification , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/microbiology , Disease Outbreaks , Drug Resistance, Microbial/genetics , Electrophoresis, Gel, Pulsed-Field , Hospitals, Veterans , Humans , Klebsiella Infections/drug therapy , Klebsiella Infections/epidemiology , Klebsiella Infections/microbiology , Klebsiella pneumoniae/genetics , Molecular Epidemiology , Ohio/epidemiology , Plasmids/genetics , Plasmids/isolation & purification
11.
Blood ; 87(10): 4316-24, 1996 May 15.
Article in English | MEDLINE | ID: mdl-8639791

ABSTRACT

PU.1, a member of the ets transcription factor family, has been previously shown to be necessary for tetradecanoylphorbol-13 acetate (TPA)-induced U937 leukemic cell maturation. We examined the effects of TPA on PU.1 content and PU.1 DNA binding activity in U937 cells. Unstimulated cells expressed PU.1 mRNA transcripts and TPA did not increase these levels. However, TPA treatment induced phosphorylation of PU.1. Gel-shift analysis using a labeled PU.1 oligomer showed that TPA induced a unique PU.1 binding activity. This binding activity was phosphorylation-dependent, as indicated by the ability of phosphatase treatment to abolish its detection. The PU.1 binding activity was generated at TPA-13 concentrations stimulating growth arrest and was blocked by the PKC inhibitor GF109203X, which antagonized TPA-induced growth inhibition. Bryostatin 1, another protein kinase C activator, induced only a modest degree of U937 growth inhibition and antagonized TPA-stimulated growth arrest. Bryostatin 1 was unable to induce this TPA-generated PU.1 binding activity. High bryostatin 1 concentrations inhibited generation of this TPA-induced band shift. These data suggest that TPA-induced growth inhibition is associated with phosphorylation of PU.1 and generation of a unique PU.1 binding activity.


Subject(s)
Gene Expression Regulation, Leukemic/drug effects , Neoplasm Proteins/metabolism , Protein Processing, Post-Translational/drug effects , Proto-Oncogene Proteins/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Trans-Activators , Transcription Factors/metabolism , Base Sequence , Bryostatins , Cell Differentiation/drug effects , Cell Division/drug effects , DNA, Neoplasm/metabolism , Enhancer Elements, Genetic , Enzyme Inhibitors/pharmacology , Humans , Indoles/pharmacology , Lactones/pharmacology , Lymphoma, Large B-Cell, Diffuse/pathology , Macrolides , Maleimides/pharmacology , Molecular Sequence Data , Neoplasm Proteins/genetics , Phosphorylation/drug effects , Protein Binding/drug effects , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/physiology , Proto-Oncogene Proteins/genetics , Proto-Oncogenes , RNA, Messenger/biosynthesis , RNA, Neoplasm/biosynthesis , Transcription Factors/genetics , Transcription, Genetic/drug effects , Tumor Cells, Cultured/drug effects
12.
J Cell Physiol ; 167(1): 113-20, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8698828

ABSTRACT

The regulated expression of protein kinase C (PKC) isoforms was examined during the differentiation program of 3T3-L1 preadipocytes. In a parallel analysis, differentiation was blocked by treatment of the cells with tumor necrosis factor-alpha (TNF) to determine differentiation-specific changes in isoform expression from growth or treatment-induced effects. This analysis revealed that the expression of the conventional PKC-alpha isoform was reduced by 85% as cells attained the adipocyte phenotype. PKC-beta expression was measurable only during the early stages of the differentiation process and was not detectable in fully differentiated cells. An upregulation of PKC-theta, a novel PKC isoform, occurred during the latter stage of differentiation. Expression of PKC-zeta an atypical PKC isoform suggested to participate in TNF signal transduction, occurred throughout the time course with similar levels of expression in both preadipocytes and adipocytes. Nuclear run-on analysis demonstrated an approximately 85% reduction in the transcription of the PKC-alpha gene during differentiation. The reduced expression of this isoform corresponded with the decreased ability to activate nuclear factor kapppaB (NF-kappaB) in response to phorbol 12-myristate 13-acetate (PMA) treatment in the adipocytes. These data suggest that PMA responsiveness in 3T3-L1 adipocytes is markedly diminished.


Subject(s)
Adipocytes/metabolism , Carcinogens/pharmacology , Isoenzymes/biosynthesis , NF-kappa B/metabolism , Protein Kinase C/biosynthesis , Tetradecanoylphorbol Acetate/pharmacology , Adipocytes/cytology , Animals , Base Sequence , Cell Differentiation/drug effects , Cells, Cultured , Mice , Molecular Sequence Data , Protein Kinase C-alpha , Recombinant Proteins/pharmacology , Signal Transduction , Tumor Necrosis Factor-alpha/pharmacology
14.
Oncol Rep ; 3(1): 213-7, 1996 Jan.
Article in English | MEDLINE | ID: mdl-21594347

ABSTRACT

In differentiating leukemic cells, cyclin-dependent kinase interacting protein (Cip1) is induced and stimulates a G(1) arrest. TPA treated U937 monoblastoid cells expressed Cip1, hypophosphorylated retinoblastoma protein (Rb), arrested in G(1) and differentiated. PKC-zeta cells are U937 cells that overexpress the zeta isoform and display alterations in endogenous PKC isoform expression. TPA treated PKC-zeta cells undergo apoptosis without differentiating. TPA treated PKC-zeta cells express Cip1 and display substantial hypophosphorylation of Rb but fail to arrest in G(1). Thus, a novel phorbol ester dependent signalling pathway exists in which Cip1 induction is associated with the absence of a G(1) arrest and induction of apoptosis rather than differentiation.

15.
Am J Physiol ; 268(5 Pt 1): E866-72, 1995 May.
Article in English | MEDLINE | ID: mdl-7762639

ABSTRACT

The purpose of the present study was to test the suitability of the rat hindlimb perfusion technique for studying the acute regulation of the GLUT-1 and GLUT-4 glucose transporter genes in adult skeletal muscle. To further examine the stability of the technique, we also monitored the transcription rate and mRNA content of selected immediate early genes. Nuclei and total RNA were isolated from red and white hindlimb muscle from perfused (2 h) and nonperfused control animals. Although GLUT-4 transcription and mRNA content remained stable, perfusion elicited a marked 3.5-fold increase in GLUT-1 mRNA in red and 2.2-fold increase in white skeletal muscle in the absence of any detectable change in transcription. In contrast to both GLUT-1 and GLUT-4, transcription originating from the c-fos and c-myc immediate early genes increased from 2.0- to 2.7-fold with perfusion in both red and white skeletal muscle, whereas transcription of the beta-actin gene decreased by 40-60%. Both c-fos and c-myc mRNA levels also increased with perfusion, whereas beta-actin mRNA remained unchanged. These findings clearly demonstrate that the current method of performing the hindlimb perfusion technique rapidly and dramatically alters the regulation of selected genes in skeletal muscle.


Subject(s)
Gene Expression , Genes, Immediate-Early , Hindlimb/blood supply , Monosaccharide Transport Proteins/metabolism , Muscle, Skeletal/physiology , Animals , Glucose Transporter Type 1 , Male , Perfusion , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Time Factors , Transcription, Genetic
16.
J Clin Invest ; 95(4): 1906-15, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7706498

ABSTRACT

Increased protein kinase C (PKC) activity in malignant breast tissue and positive correlations between PKC activity and expression of a more aggressive phenotype in breast cancer cell lines suggest a role for this signal transduction pathway in the pathogenesis and/or progression of breast cancer. To examine the role of PKC in the progression of breast cancer, human MCF-7 breast cancer cells were transfected with PKC-alpha, and a group of heterogenous cells stably overexpressing PKC-alpha were isolated (MCF-7-PKC-alpha). MCF-7-PKC-alpha cells expressed fivefold higher levels of PKC-alpha as compared to parental or vector-transfected MCF-7 cells. MCF-7-PKC-alpha cells also displayed a substantial increase in endogenous expression of PKC-beta and decreases in expression of the novel delta- and eta-PKC isoforms. MCF-7-PKC-alpha cells displayed an enhanced proliferative rate, anchorage-independent growth, dramatic morphologic alterations including loss of an epithelioid appearance, and increased tumorigenicity in nude mice. MCF-7-PKC-alpha cells exhibited a significant reduction in estrogen receptor expression and decreases in estrogen-dependent gene expression. These findings suggest that the PKC pathway may modulate progression of breast cancer to a more aggressive neoplastic process.


Subject(s)
Breast Neoplasms/enzymology , Breast Neoplasms/etiology , Isoenzymes/biosynthesis , Isoenzymes/genetics , Protein Kinase C/biosynthesis , Protein Kinase C/genetics , Animals , Blotting, Northern , Blotting, Western , Breast Neoplasms/pathology , Breast Neoplasms/ultrastructure , Cell Adhesion , Cell Cycle , Female , Humans , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Invasiveness , Neoplasm Metastasis , Phenotype , Protein Kinase C-alpha , Recombinant Proteins/biosynthesis , Transfection
17.
Cell Growth Differ ; 5(11): 1195-203, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7848921

ABSTRACT

A function for protein kinase C-zeta (PKC-zeta), a member of the phorbol ester nonresponsive atypical protein kinase C subfamily, in modulating differentiation was examined in the leukemic U937 cell. Transfected U937 cells stably overexpressing PKC-zeta displayed a longer doubling time, lower saturation density at confluency, and an increase in adherence to plastic as compared to control cells. PKC-zeta cells expressed a more differentiated phenotype as assessed by changes in morphology, surface antigen expression, and lysosomal enzyme activities and were distinct from parental U937 cells stimulated to differentiate by exposure to phorbol esters. In contrast to parental U937 cells, PKC-zeta cells constitutively expressed mRNA transcripts for c-jun and a low mobility AP-1 binding activity. Thus, PKC-zeta overexpression stimulates a type of phenotypic differentiation that differs significantly from maturation occurring upon activation of other PKC subfamilies induced by phorbol ester treatment. Increased expression of the c-jun protooncogene and an increase in AP-1 binding activity in PKC-zeta cells provides a potential mechanism for explaining the altered differentiation status of this cell.


Subject(s)
Gene Expression , Isoenzymes/physiology , Monocytes/cytology , Protein Kinase C/metabolism , Antigens, CD/biosynthesis , Cell Adhesion , Cell Differentiation/drug effects , Cell Division , Cell Size , Humans , Isoenzymes/biosynthesis , Leukemia/enzymology , Leukemia/pathology , Lysosomes/enzymology , Monocytes/enzymology , Protein Kinase C/biosynthesis , Proto-Oncogene Proteins c-jun/biosynthesis , RNA, Messenger/biosynthesis , Tetradecanoylphorbol Acetate/pharmacology , Transcription Factor AP-1/metabolism , Transfection , Tumor Cells, Cultured
18.
Oncol Rep ; 1(1): 17-26, 1994 Jan.
Article in English | MEDLINE | ID: mdl-21607300

ABSTRACT

Malignant transformation by the v-src oncogene and mitogenic stimulation by interleukin-3 (IL-3) both increased glucose transport into a hematopoietic cell line. These increases were additive and correlated with elevations in the level of GLUT1 mRNA. Glucose transport and GLUT1 mRNA were dependent on the presence of a functional v-src gene product in the absence of IL-3. Nuclear run-on analyses and mRNA turnover experiments demonstrated that GLUT1 gene transcription was enhanced by v-src while IL-3 stabilized GLUT1 mRNA. Introduction of retroviruses overexpressing GLUT1 into factor-dependent cells did not abrogate factor-dependency. Thus, GLUT1 induction is necessary but not sufficient for mitogenesis.

19.
Oncogene ; 8(11): 2905-15, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8414494

ABSTRACT

The mechanisms responsible for abrogation of the growth factor-dependency of a hematopoietic cell line were investigated. FDC-P1 cells were infected with retroviral constructs containing the neo gene and either a wild-type or a temperature-sensitive v-src oncogene. v-srcwt abrogated the factor-dependency of these cells since each G418r colony gave rise to factor-independent cells and no autocrine growth factor activity was detected. Moreover, the vast majority (< 99%) of cells infected with the v-srcts mutant gave rise to conditional factor-independent cells. Therefore a functional v-src gene product was required for growth factor-independence which occurred by a non-autocrine mechanism. A minority of factor-independent cells which arose after v-srcts infection, grew at the non-permissive temperature and one-half secreted granulocyte/macrophage-colony stimulating factor (GM-CSF) which supports the growth of the parental cells. Since the v-srcts viral stock contained a helper virus, Murine Leukemia Virus (MuLV), the ability of this virus to relieve factor-dependency was examined. A low frequency of factor-independent transformants was recovered after MuLV infection and one-half secreted GM-CSF. Therefore, retroviruses such as MuLV which lack an oncogene, can transform cells by stimulating autocrine growth factor secretion. Subsequent experiments performed with helper-free v-src preparations indicated that they could abrogate factor-dependency directly by a non-autocrine mechanism. These results demonstrate that a hematopoietic cell line can be transformed by two different mechanisms after retroviral infection and may be relevant for understanding hematopoietic cell transformation after persistent viral infection.


Subject(s)
Cell Transformation, Neoplastic , Genes, src , Growth Substances/pharmacology , Hematopoietic Stem Cells/cytology , Retroviridae/genetics , Animals , Cell Division , Cell Line , Cell Line, Transformed , DNA/biosynthesis , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cells/microbiology , Mice , Oncogene Protein pp60(v-src)/physiology , Proviruses/genetics , Proviruses/isolation & purification , Proviruses/physiology , Retroviridae/physiology , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL
...